AFP and neoplasm: In BCLC 0/A, TARE-treated patients had higher median AFP levels (8.9 vs. 8.0, p = 0.046) and a larger maximum tumor diameter (4.2 [2.3–5.8] vs. 2.7 [1.8–3.7] cm, p = 0.001).